Damon B Dixon1, Annabel P Kornblum1, Lyn M Steffen2, Xia Zhou2, Julia Steinberger3. 1. Division of Cardiology, Department of Pediatrics, University of Minnesota, Minneapolis, MN. 2. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN. 3. Division of Cardiology, Department of Pediatrics, University of Minnesota, Minneapolis, MN. Electronic address: stein055@umn.edu.
Abstract
OBJECTIVE: To assess the awareness and implementation of lipid guidelines among primary pediatric providers. STUDY DESIGN: An online survey was administered to primary pediatric providers (n = 1488): pediatricians, family medicine/general practitioners, and advanced practitioners (nurse practitioners/physician assistants) in Minnesota. The survey was conducted over 12 weeks in 2012-2013. A multiple-choice questionnaire was used to evaluate the participants' knowledge, screening, and management attitudes regarding pediatric lipid guidelines. RESULTS: The overall response rate was 39% (n = 548 of 1402 successful e-mails). Respondents were primarily pediatricians and family medicine practitioners (37% each), followed by general practitioners (11%) and advanced practitioners (nurse practitioners, 5.5%; physician assistants, 1.6%). Although 74% of providers reportedly believed that lipid screening and treatment would reduce future cardiovascular risk, 34% performed no screening, 50% screened selectively, and only 16% performed universal screening. Pediatricians were more likely to screen, with 30% performing universal screening and 41% performing selective screening. Among perceived barriers to screening, providers reported uneasiness addressing lipid disorders (43%), and unfamiliarity with screening guidelines (31%). The majority (83%) were uncomfortable managing lipid disorders, and 57% were opposed to the use of lipid-lowering medications in children. CONCLUSION: These findings underscore the need to further educate providers and supply easily accessible information on the screening and treatment of childhood lipid disorders.
OBJECTIVE: To assess the awareness and implementation of lipid guidelines among primary pediatric providers. STUDY DESIGN: An online survey was administered to primary pediatric providers (n = 1488): pediatricians, family medicine/general practitioners, and advanced practitioners (nurse practitioners/physician assistants) in Minnesota. The survey was conducted over 12 weeks in 2012-2013. A multiple-choice questionnaire was used to evaluate the participants' knowledge, screening, and management attitudes regarding pediatric lipid guidelines. RESULTS: The overall response rate was 39% (n = 548 of 1402 successful e-mails). Respondents were primarily pediatricians and family medicine practitioners (37% each), followed by general practitioners (11%) and advanced practitioners (nurse practitioners, 5.5%; physician assistants, 1.6%). Although 74% of providers reportedly believed that lipid screening and treatment would reduce future cardiovascular risk, 34% performed no screening, 50% screened selectively, and only 16% performed universal screening. Pediatricians were more likely to screen, with 30% performing universal screening and 41% performing selective screening. Among perceived barriers to screening, providers reported uneasiness addressing lipid disorders (43%), and unfamiliarity with screening guidelines (31%). The majority (83%) were uncomfortable managing lipid disorders, and 57% were opposed to the use of lipid-lowering medications in children. CONCLUSION: These findings underscore the need to further educate providers and supply easily accessible information on the screening and treatment of childhood lipid disorders.
Authors: Joshua W Knowles; Emily C O'Brien; Karen Greendale; Katherine Wilemon; Jacques Genest; Laurence S Sperling; William A Neal; Daniel J Rader; Muin J Khoury Journal: Am Heart J Date: 2014-09-16 Impact factor: 4.749
Authors: Nina R Joyce; Justin P Zachariah; Charles B Eaton; Amal N Trivedi; Gregory A Wellenius Journal: Acad Pediatr Date: 2017-02-21 Impact factor: 3.107
Authors: Matthew L Basiaga; Evanette K Burrows; Michelle R Denburg; Kevin E Meyers; Andrew B Grossman; Petar Mamula; Robert W Grundmeier; Jon M Burnham Journal: J Pediatr Date: 2016-09-09 Impact factor: 4.406
Authors: Justin P Zachariah; Catherine J McNeal; Laurel A Copeland; Ying Fang-Hollingsworth; Eileen M Stock; FangFang Sun; Joon Jin Song; Sean T Gregory; Jeffrey O Tom; Eric A Wright; Jeffrey J VanWormer; Andrea E Cassidy-Bushrow Journal: J Clin Lipidol Date: 2015-07-09 Impact factor: 4.766
Authors: Justin H Berger; Feiyan Chen; Jennifer A Faerber; Michael L O'Byrne; Julie A Brothers Journal: Am Heart J Date: 2020-10-24 Impact factor: 4.749